74
Participants
Start Date
April 26, 2021
Primary Completion Date
June 1, 2024
Study Completion Date
October 1, 2024
Application and measurement of tumor vascularization using diagnostic contrast enhanced ultrasound (CEUS)
"Part A: performing CEUS with the contrast agent SonoVue® at two different doses and two different injection speeds in participants with primary breast cancer~Part B: performing CEUS with the contrast agent SonoVue® using the established protocol from part A in participants undergoing neoadjuvant chemotherapy~Part C: performing CEUS with the contrast agent SonoVue® using the established protocol from part A in participants with lesions of unknown dignity"
RECRUITING
Department of Gynecology and Obstetrics Universitätsklinikum Aachen, AöR, Aachen
RWTH Aachen University
OTHER